ConductScience.org, home

Paper715674

The necessity of increased doses of amikacin in burn patients.

Zaske DE and 2 others. Surgery, 1978. Cited by 62 papers, by iCite.

Cite this record

ConductScience Library. The necessity of increased doses of amikacin in burn patients. Papers, record 715674. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/715674

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The necessity of increased doses of amikacin in burn patients.
PubMed
Journal
Surgery
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
3.68
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zaske DED E
2Sawchuk RJR J
3Strate RGR G

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmikacinMajor topic
Bacterial InfectionsMajor topic
BurnsMajor topic
KanamycinMajor topic
Adolescent
Adult
Aged
Creatinine
Half-Life
Humans
Infant
Middle Aged

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
32055559Augmented renal clearance.Transl Clin Pharmacol2018https://conductscience.org/library/papers/32055559PubMed
21825289Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21825289PubMed
18783295Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.Clin Pharmacokinet2008https://conductscience.org/library/papers/18783295PubMed
16723549Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16723549PubMed
16176116Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.Clin Pharmacokinet2005https://conductscience.org/library/papers/16176116PubMed
14503658Relative pharmacokinetics of three amikacin brands in onco-hemotologic pediatric patients experiencing febrile neutropeina.Eur J Drug Metab Pharmacokinet2003https://conductscience.org/library/papers/14503658PubMed
10582870Pharmacokinetics of cefepime in patients with thermal burn injury.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10582870PubMed
9559811Fluconazole pharmacokinetics in burn patients.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9559811PubMed
8787895Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8787895PubMed
7586895Clinical pharmacokinetics in patients with burns.Clin Pharmacokinet1995https://conductscience.org/library/papers/7586895PubMed
7036923Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function.Ann Surg1982https://conductscience.org/library/papers/7036923PubMed
3977436Amikacin concentrations in serum following intraoperative irrigation of the pleura and peritoneum.Ann Surg1985https://conductscience.org/library/papers/3977436PubMed
2360818Vancomycin pharmacokinetics in burn patients and intravenous drug abusers.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2360818PubMed
2360811Increased aminoglycoside dosage requirements in hematologic malignancy.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2360811PubMed
2180612Pathophysiology and pharmacokinetics following burn injury.Clin Pharmacokinet1990https://conductscience.org/library/papers/2180612PubMed
2014982Aztreonam pharmacokinetics in burn patients.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/2014982PubMed
1929317Gentamicin pharmacokinetics in patients with malignancies.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1929317PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/715674

GET https://conductscience.org/api/papers/v1/715674/authors